Enter your drug, current dose and start date. You get your spot on the approved ladder, how long you've been there, and the earliest labeled interval before a change. This is not a recommendation to increase your dose. It remembers, so next week you just open it.
Four weeks at each dose is a floor, not a target. Every approved GLP-1 ladder is built on it. Gut side effects track how fast the dose rises more than the dose itself, and the trials behind the efficacy numbers used this schedule.
This tool shows the earliest labeled interval before a change, not a reason to make one. Plenty of people stay at a mid-ladder dose for months because it works, or because moving up made them miserable. Both are normal, and both are your prescriber's call.
| Drug | Steps, weekly |
|---|---|
| Wegovy / Wegovy HD | 0.25 → 0.5 → 1 → 1.7 → 2.4 mg, then 7.2 mg (Wegovy HD, approved March 2026) |
| Wegovy pill | Once-daily tablet on an empty stomach, stepped up monthly to the 25 mg maintenance dose; not tracked here |
| Foundayo (orforglipron) | Once-daily tablet, with or without food, stepped up per label; not tracked here |
| Ozempic | 0.25 → 0.5 → 1 → 2 mg — indicated for type 2 diabetes |
| Zepbound / Mounjaro | 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg |
On a compounded dose that isn't on any ladder? See the switching page. There is no clean mapping, and the number is not yours to pick.
Where your weight should be by this week · Whether your stall is actually a stall · What tends to happen after a step up · Your protein target at this weight
Information, not medical advice. This is a calendar, not a prescriber: it recommends no dose, change or timing, and can't see your history or how you're tolerating treatment. Never change, skip or double a dose without your prescriber. Missed a dose? Check your product's label or call your prescriber instead of guessing.
Three questions tell you the cheapest way to start — with insurance, direct from Lilly or Novo, or through a compounding pharmacy.
Find my cheapest route →One short email a week on GLP-1 treatment: what the trials and prescribing labels describe at each stage, and changes in cost and access. General information, not tied to a particular medication or dose. For the trial average for your own medication, use the curve calculator.
No spam. Unsubscribe any time. Educational information only, not medical advice.